Can Mendelian Randomization Help Us Understand Frailty? A Conversation Between Two Camps
This post, with assistance from AI, envisions a lively debate about the pros and cons of using Mendelian randomization to advance causal inference in frailty research.
Mendelian Randomization: A Natural Experiment
Moderator: Before we begin the debate, let’s briefly explain what Mendelian randomization (MR) is.
Unlike a randomized clinical trial (RCT), MR does not assign people to different treatments. Instead, it takes advantage of the random allocation of genetic variants at conception. If certain genetic variants are known to influence an exposure, for example, body mass index (BMI), inflammatory signaling, or LDL cholesterol, and those same variants are also associated with frailty, MR can provide evidence supporting a causal relationship.
The simplest MR estimate is remarkably intuitive:
Causal effect ≈ (genetic effect on the outcome) ÷ (genetic effect on the exposure).
However, this interpretation relies on three key assumptions:
- Relevance: the genetic variant truly influences the exposure.
- Independence: the variant is not associated with confounders.
- Exclusion restriction: the variant affects the outcome only through the exposure, not through another biological pathway (i.e., no horizontal pleiotropy).
When these assumptions are reasonably satisfied, MR can strengthen causal inference, particularly when randomized trials are impractical or unethical.
So far, most MR studies of frailty have used either the Frailty Phenotype (FP) or the Frailty Index (FI) as the outcome.
But is one more appropriate than the other?
Let’s listen in.
Camp Phenotype
“I think the Frailty Phenotype is the more appropriate outcome for MR.
The original phenotype was developed from a biological hypothesis—that aging-associated dysregulation across multiple physiological systems, including inflammatory, neuroendocrine, musculoskeletal, and energy-metabolism pathways, eventually manifests as weakness, slowness, exhaustion, weight loss, and low physical activity.
MR is fundamentally about understanding causal pathways. If inflammation, obesity, or metabolic dysregulation causally increase the risk of the frailty phenotype, that tells us something meaningful about mechanisms leading to this clinical syndrome.”
Camp Deficit Accumulation
“But you’re assuming that frailty is primarily a biological syndrome.
Our model starts from a different premise.
Frailty reflects the accumulation of health deficits across multiple domains – physical, cognitive, psychological, nutritional, functional, and social. Aging itself is multidimensional. Why should the outcome be restricted to physical manifestations?
The Frailty Index captures precisely what aging looks like in real patients.”
Camp Phenotype
“I don’t disagree that aging is multidimensional.
My concern is interpretability.
The Frailty Index contains chronic diseases, disabilities, symptoms, and self-reported health.
Suppose an MR study finds that genetically higher BMI increases the Frailty Index.
What exactly has BMI caused?
Has it caused frailty?
Or has it increased diabetes, osteoarthritis, hypertension, and disability, all of which contribute directly to the index?
The causal interpretation becomes less specific.”
Camp Deficit Accumulation
“But why is that a problem?
Frailty, in our framework, is health deficit accumulation.
If obesity increases the accumulation of deficits, then obesity increases frailty.
That is exactly what the Frailty Index is designed to measure.
You’re criticizing the outcome because it doesn’t fit the phenotype definition of frailty.”
Camp Phenotype
“Perhaps.
But then we’re answering different questions.
An MR study using the phenotype asks:
Does this exposure increase the risk of developing the clinical syndrome of frailty?
An MR study using the Frailty Index asks:
Does this exposure increase overall health deficit accumulation?
Those are related questions, but they are not identical.”
Camp Deficit Accumulation
“I would also point out that the phenotype is hardly biologically pure.
Weakness, exhaustion, weight loss, and slowness can all result from heart failure, COPD, depression, arthritis, cancer, or socioeconomic disadvantage.
The phenotype is also influenced by multiple pathways.
It is no more immune to heterogeneity than the Frailty Index.”
Camp Phenotype
“That’s true.
The difference isn’t that one is heterogeneous and the other isn’t.
The difference is that the phenotype attempts to identify a recognizable clinical syndrome, whereas the Frailty Index intentionally summarizes overall vulnerability.
One emphasizes a syndrome.
The other emphasizes cumulative burden.
Some have argued that defining frailty as a syndrome merely identifies individuals without pointing toward interventions. But identifying the syndrome is never meant to end at the criteria; it serves as the clinical gateway to elucidating the underlying etiology and biological dysregulation, which is precisely where the targets for intervention lie.”
Moderator
“Perhaps this debate reflects different definitions of frailty rather than different statistical methods.
MR estimates the causal effect on whatever outcome is chosen.
It cannot determine whether one conceptualization of frailty is more ‘correct.'”
An Unexpected Finding: What About Physical Activity?
Moderator: One finding from recent MR studies has generated considerable discussion.
Several studies have found little or no evidence that genetically predicted moderate-to-vigorous physical activity reduces the risk of frailty.
This appears inconsistent with decades of observational research and randomized exercise trials.
How should we interpret this?
Camp Deficit Accumulation
“This illustrates the limitations of MR.
The available genetic instruments explain only a tiny proportion of lifetime physical activity.
Moreover, genes associated with physical activity may reflect a predisposition to be active rather than the effects of structured exercise interventions.
A null MR finding should not be interpreted as evidence that exercise does not prevent frailty.”
Camp Phenotype
“I agree.
Exercise trials randomize an intervention over months or years, often in older adults already at risk.
MR estimates the consequences of lifelong genetically influenced differences in activity.
Those are fundamentally different causal questions.
The discrepancy reminds us that MR complements, not replaces, clinical trials.”
Camp Deficit Accumulation
“We also cannot overlook how easily core MR assumptions can be violated in practice. When studies rely on a broad ‘menu’ of genetic variants, the exclusion restriction and the requirement that variants have no paths through unmeasured confounders become exceedingly tenuous.
Certain exposure–outcome combinations are especially vulnerable, particularly broad behavioral (e.g., physical activity) or psychosocial exposures. For these complex exposures, genetic variants are far more likely to influence frailty through multiple alternative biological pathways rather than exclusively through the exposure itself.”
Camp Phenotype:
“Exactly. And it reinforces that frailty develops through complex interactions between genetics, environment, disease, and life experiences accumulated over decades. Genes are only one piece of the puzzle.
Rather than treating MR as definitive proof, we must view it as just one component of evidence triangulation alongside observational epidemiology and randomized clinical trials.”
Moderator
“So perhaps the lesson isn’t that MR has failed.
Rather, it tells us that causal inference depends not only on valid genetic instruments, but also on thoughtful definition of the outcome.”
Where Both Camps Agree
Despite their differences, both camps find common ground.
They agree that:
- Chronic inflammation receives increasingly strong causal support from MR.
- Cardiometabolic risk factors, including obesity and hypertension, appear to contribute causally to frailty or health deficit accumulation.
- Vitamin D, C-reactive protein, coffee, tea, and several other commonly studied exposures have shown little convincing causal evidence despite observational associations.
- MR is not a stand-alone adjudicator: because instrumental variable assumptions (especially exclusion restriction) are difficult to verify when utilizing many polygenic variants for complex behavioral or psychosocial traits, MR must be integrated into a triangulation framework alongside observational studies and intervention trials.
Most importantly, both agree that different frailty measures are complementary rather than interchangeable. They identify overlapping but distinct populations and predict many of the same adverse outcomes, while capturing different dimensions of vulnerability.
Final Thoughts
Perhaps the debate is not really about Mendelian randomization.
It is about what we mean by frailty.
If frailty is viewed as a distinct clinical syndrome arising from multisystem physiological dysregulation, the Frailty Phenotype may be the more natural MR outcome.
If frailty is viewed as the accumulation of age-related deficits across multiple domains, the Frailty Index is equally appropriate.
Rather than asking which measure is “right,” a more productive question may be:
What causal question is each measure designed to answer?
Viewed through that lens, Mendelian randomization is not adjudicating between competing models of frailty; it is helping us understand different facets of one of geriatrics’ most complex and fascinating constructs.
